<DOC>
	<DOCNO>NCT02973269</DOCNO>
	<brief_summary>The specific aim study compare safety efficacy single administration DaxibotulinumtoxinA Injection versus placebo manage plantar fasciitis .</brief_summary>
	<brief_title>DaxibotulinumtoxinA Injection Management Plantar Fasciitis</brief_title>
	<detailed_description />
	<mesh_term>Fasciitis</mesh_term>
	<mesh_term>Fasciitis , Plantar</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Written inform consent , include authorization release health information Skeletally mature , male female patient 18 65 year age diagnosis plantar fasciitis Persistent heel pain three month Women child bear potential must negative urine pregnancy test ( UPT ) Screening Visit must use effective method birth control course study Previous surgery midfoot hindfoot Neuromuscular disease Systemic muscle weakness Planning pregnancy study Current enrollment investigational drug device study participation study within last 30 day prior first visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>